viernes, 8 de mayo de 2026
Editorial e321 BMI-based barriers to joint replacement in the UK The Lancet Rheumatology ++... ++
A treat-to-target strategy versus symptom-driven management of gout in the Netherlands (GO TEST Overture): a multicentre, open-label, pragmatic, superiority, randomised controlled trial
Anusha Moses, MSca Send email to anusha.moses93@icloud.com ∙ Martijn A H Oude Voshaar, PhDa,b ∙ Eva H van Geel, MDc ∙ Lydia Schipper, PhDd ∙ Iris Rose Peeters, MSce ∙ Reinhard Bos, MDf ∙ et al.
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(26)00034-2/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz-9YcV1ryusvlxn-s2Dj5sBEXS-tfi5HWv6T7rO5ogHFittaPLGFaHfakXmbF_wTRRFDSHRboMqFh6qw7wRKMp3ONJBz6g&_hsmi=417533247&utm_content=417236216&utm_source=hs_email
Editorial
e321
BMI-based barriers to joint replacement in the UK
The Lancet Rheumatology
https://www.thelancet.com/journals/lanrhe/issue/vol8no5/PIIS2665-9913(26)X2004-5
Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumab
Prof Athimalaipet V Ramanan, FMedScia Send email to a.ramanan@bristol.ac.uk ∙ Prof Nicolino Ruperto, MDb ∙ Ivan Foeldvari, MDc ∙ Gabriel Vega-Cornejo, MDd ∙ Stuart Keller, BSce ∙ Rona Wang, MDe ∙ et al.
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00346-7/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz-_yXMU3yvh6cGtNHZfvR8wum7Zj2NGJDrfDYJpEpg4dee5tjBp9xLyq7rUHxTaK_uhL81RUE02DZ2K8AHyv9SIM_zChXw&_hsmi=417533247&utm_content=417236216&utm_source=hs_email
Glucocorticoid treatment in patients with inflammatory rheumatic diseases: current practice and open questions
Prof Frank Buttgereit, MDa,b Send email to frank.buttgereit@charite.de ∙ Prof Lai-Shan Tam, MD
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(26)00072-X/fulltext?dgcid=hubspot_update_feature_updatealerts_lanrhe&utm_campaign=update-lanrhe&utm_medium=email&_hsenc=p2ANqtz--SBOtrnS6uLyS5SGnZXsXVAJX5Hm20o_vLUXUoASQvW0RNyFrtPJFlrMDbWuacQb7LANUsPO3T9koY2lWcIoyyI8VNMw&_hsmi=417533247&utm_content=417236216&utm_source=hs_email
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario